Sustained improvements in patient-reported outcomes in psoriatic arthritis patients treated with etanercept - 21/08/11
Philip Mease, MD, Seattle Rheumatology Associates, Seattle, WA, United States; Alice Gottlieb, MD, PhD, UMDNJ—Robert Wood Johnson Medical Center, New Brunswick, NJ, United States; J. Michael Woolley, PhD, Amgen Inc., Thousand Oaks, CA, United States; Meleana Dunn, MS
Le texte complet de cet article est disponible en PDF. P5 Dr. Mease receives grant support from Amgen for conducting clinical trials and is a consultant for and a member of the speakers bureau for Amgen. Research funded by Immunex Corporation, a wholly owned subsidiary of Amgen Inc., and by Wyeth Research. |
Vol 52 - N° 3S
P. P2 - mars 2005 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?